TCP11L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.295200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.567000E-01
Normal-vs-Stage2
7.406200E-01
Normal-vs-Stage3
8.005400E-01
Normal-vs-Stage4
5.532400E-01
Stage1-vs-Stage2
9.320600E-01
Stage1-vs-Stage3
5.835200E-01
Stage1-vs-Stage4
8.175400E-01
Stage2-vs-Stage3
5.306200E-01
Stage2-vs-Stage4
6.992600E-01
Stage3-vs-Stage4
3.776600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.566400E-01
Normal-vs-AfricanAmerican
5.909800E-01
Normal-vs-Asian
8.520600E-01
Caucasian-vs-AfricanAmerican
5.593200E-01
Caucasian-vs-Asian
3.390200E-01
AfricanAmerican-vs-Asian
3.345800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.314600E-01
Normal-vs-Female
6.135400E-01
Male-vs-Female
3.701200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.525800E-01
Normal-vs-Age(41-60Yrs)
3.839800E-01
Normal-vs-Age(61-80Yrs)
9.478800E-01
Normal-vs-Age(81-100Yrs)
9.654600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.587400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.108000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.473600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.699500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.314050E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.684600E-01
Normal-vs-Daily Drinker
5.667600E-01
Normal-vs-Weekly Drinker
8.139200E-01
Normal-vs-Occasional Drinker
6.027400E-01
Normal-vs-Social Drinker
3.943400E-01
Non Drinker-vs-Daily Drinker
5.003200E-01
Non Drinker-vs-Weekly Drinker
4.460400E-01
Non Drinker-vs-Occasional Drinker
1.324790E-01
Non Drinker-vs-Social Drinker
2.506100E-02
Daily Drinker-vs-Weekly Drinker
1.702800E-01
Daily Drinker-vs-Occasional Drinker
6.112300E-02
Daily Drinker-vs-Social Drinker
2.031600E-02
Weekly Drinker-vs-Occasional Drinker
5.457400E-01
Weekly Drinker-vs-Social Drinker
2.126800E-01
Occasional Drinker-vs-Social Drinker
4.879400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.757600E-01
Normal-vs-Grade 2
1.214380E-01
Normal-vs-Grade 3
1.382590E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.082400E-02
Grade 1-vs-Grade 3
1.155600E-01
Grade 1-vs-Grade 4
3.757600E-01
Grade 2-vs-Grade 3
8.491200E-01
Grade 2-vs-Grade 4
1.214380E-01
Grade 3-vs-Grade 4
1.382590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.028800E-01
Normal-vs-NonDiabetic
8.153200E-01
Diabetic-vs-NonDiabetic
7.429000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.692800E-01
Normal-vs-NoPancreatitis
8.138400E-01
Pancreatitis-vs-NoPancreatitis
7.026200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.084000E-01
Normal-vs-N1
7.375400E-01
N0-vs-N1
6.794400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.459200E-01
Normal-vs-TP53-NonMutant
7.424800E-01
TP53-Mutant-vs-TP53-NonMutant
5.824400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
